Logo
x

Search

Subscribe Now

Abbott

Abbott Reports the Initiation of TRANSCEND Trial Assessing Deep Brain Stimulation System to Manage Severe Depression (TRD)

Abbott Reports the Initiation of TRANSCEND Trial Assessing Deep Brain Stimulation System to Manage Severe Depression (TRD)

  • September 5, 2024
Abbott Updates Heart Failure Management by Excluding Aspirin for Patients with the HeartMate 3 Heart Pump

Abbott Updates Heart Failure Management by Excluding Aspirin for Patients with the HeartMate 3 Heart Pump

  • August 23, 2024
Abbott Partners with Medtronic for Continuous Glucose Monitoring System to Improve Diabetes Care

Abbott Partners with Medtronic for Continuous Glucose Monitoring System to Improve Diabetes Care

  • August 9, 2024
The US FDA Clears Abbott’s Two New Over-The-Counter Continuous Glucose Monitoring Systems

The US FDA Clears Abbott’s Two New Over-The-Counter Continuous Glucose Monitoring Systems

  • June 11, 2024
Abbott’s AVEIR Dual Chamber Leadless Pacemaker System Gains CE Mark to Treat Abnormal or Slow Heart Rhythms

Abbott’s AVEIR Dual Chamber Leadless Pacemaker System Gains CE Mark to Treat Abnormal or Slow Heart Rhythms

  • June 7, 2024
Abbott's Esprit BTK System Gains the US FDA’s Approval for Chronic Limb-Threatening Ischemia (CLTI) Below-The-Knee (BTK)

Abbott's Esprit BTK System Gains the US FDA’s Approval for Chronic Limb-Threatening Ischemia (CLTI) Below-The-Knee (BTK)

  • April 30, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.